Moderna Stock Leapt 4.5% After Joining S&P 500. Why Analysts Don’t Expect More Gains.

Text dimension Moderna’s vaccine has confirmed the worth of its mRNA know-how. Munir Uz zaman/AFP through Getty Images Biotech firm

Read more

Just give us the vaccines, WHO pleads, as poor countries go wanting | India News – Times of India

GENEVA: Rich countries are opening up societies and vaccinating younger people who find themselves not at nice danger from Covid-19,

Read more